Fellow, Global Patient Safety and Pharmacovigilance en Butler University

Structure: 

Fellows will begin with the academic sector at Butler University for 6 months and then move into their industry setting at Eli Lilly and Company for 18 months. 

Currently, the FDA had to suspend recruitment for the 2026-2028 fellowship cycle. It is our hope that the FDA experience will continue, but at this time, we cannot guarantee it.   However, we are confident that this fellowship will continue to provide high-quality safety and regulatory experiences. 

Objectives:

• Examine career options within academic, pharmaceutical industry, medical, and regulatory environments. 
• Demonstrate an understanding of the key elements of an academic environment and faculty roles within it. 
• Explore various medical and regulatory components of pharmaceutical development and innovation. 
• Develop an understanding of regulations and patient safety considerations regarding medication use. 
• Construct expertise in patient and medication safety, focusing on tools and methods to make healthcare safer. 
• Demonstrate personal, interpersonal, and teamwork skills critical for effective leadership. 
• Focus on regulatory approaches in addressing risk management and medication error related issues associated with currently marketed drug and biologic products. 
• Contribute to advancing the science of risk management and medication error prevention and analysis. 
• Develop and understanding of pharmaceutical risk management tools available to assess and mitigate the risks of drug and biologic products. 
• Enhance scientific writing skills. 
• Engage at scientific conferences to network with other professionals in industry 

Eligibility: 

Fellows must have graduated from an ACPE accredited college of pharmacy, or otherwise eligible for licensure as a pharmacist, prior to the start of the fellowship term. All applicants must be U.S. citizens due to the potential for rotating with the FDA. Candidates who do not meet this requirement should not apply. 

Application Materials: 

Interested applicants must submit the following: 

• Letter of intent o
  •  Please address to: 

Veronica Vernon, PharmD, BCPS, BCACP, MSCP, FAphA 

Associate Professor and Chair of Pharmacy Practice 

Butler University College of Pharmacy and Health Sciences

Indianapolis, IN, USA 

o Please submit under “Cover Letter” on the application 

• Curriculum vitae 
• Two letters of reference emailed to [email protected] by October 27^th 2025 • Unofficial transcripts 
  • Submission of an unofficial application to Oracle will be used a placeholder.
  • Please email your official transcript to [email protected] by October 27^th 2025. 

About Butler University College of Pharmacy and Health Sciences 

Located in Indianapolis, Indiana, Butler University is a nationally recognized university with seven academic colleges.  In 2025, Butler was ranked as the top regional university in the Midwest by U.S. News & World Report, the most innovative among Midwest Regional Universities.  At the Butler University College of Pharmacy & Health Sciences, you will find a community of health professionals committed to excellence. Our programs prepare students and post-graduate learners to become leaders in their chosen fields. Butler University College of Pharmacy and Health Sciences has a variety of post-graduate residencies and fellowships, each designed to strengthen not only the professionals’ specialty expertise, but also enhance teaching abilities in the classroom through faculty direction and mentorship. 

About Eli Lilly and Company 

For nearly 150 years, Lilly has developed and delivered trusted medicines to more than 58 million people around the world. Their growing portfolio of medicines includes treatments in the areas of cancer, diabetes, endocrinology, immunology, neuroscience, obesity and more. Lilly’s Global Patient Safety organization, consisting of more than 300 physicians, pharmacists, nurses and other health care professionals, is dedicated to the collection, monitoring, evaluation and reporting of safety information through the science of pharmacovigilance. 

Please email [email protected] with any questions you have. 

Company